Literature DB >> 30097692

The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses.

Carla Eller1,2, Laura Heydmann1,2, Che C Colpitts3, Eloi R Verrier1,2, Catherine Schuster1,2, Thomas F Baumert4,5,6.   

Abstract

Chronic hepatitis B, C and D virus (HBV, HCV and HDV) infections are a major cause of liver disease and cancer worldwide. Despite employing distinct replication strategies, the three viruses are exclusively hepatotropic, and therefore depend on hepatocyte-specific host factors. The sodium taurocholate co-transporting polypeptide (NTCP), a transmembrane protein highly expressed in human hepatocytes that mediates the transport of bile acids, plays a key role in HBV and HDV entry into hepatocytes. Recently, NTCP has been shown to modulate HCV infection of hepatocytes by regulating innate antiviral immune responses in the liver. Here, we review the current knowledge of the functional role and the molecular and cellular biology of NTCP in the life cycle of the three major hepatotropic viruses, highlight the impact of NTCP as an antiviral target and discuss future avenues of research.

Entities:  

Keywords:  Anti-viral therapy; Bile acid transport; Hepatocytes; Host factor; Liver cell biology

Mesh:

Substances:

Year:  2018        PMID: 30097692      PMCID: PMC7613421          DOI: 10.1007/s00018-018-2892-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  114 in total

1.  Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.

Authors:  Florian A Lempp; Ellen Wiedtke; Bingqian Qu; Pierre Roques; Isabelle Chemin; Florian W R Vondran; Roger Le Grand; Dirk Grimm; Stephan Urban
Journal:  Hepatology       Date:  2017-07-18       Impact factor: 17.425

Review 2.  Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.

Authors:  Julie Lucifora; Ulrike Protzer
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

Review 3.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

4.  Dephosphorylation of Ser-226 facilitates plasma membrane retention of Ntcp.

Authors:  M Sawkat Anwer; Henry Gillin; Sunil Mukhopadhyay; Natarajan Balasubramaniyan; Federick J Suchy; Meenakshisundaram Ananthanarayanan
Journal:  J Biol Chem       Date:  2005-07-18       Impact factor: 5.157

5.  Sodium taurocholate cotransporting polypeptide is a serine, threonine phosphoprotein and is dephosphorylated by cyclic adenosine monophosphate.

Authors:  S Mukhopadhyay; M Ananthanarayanan; B Stieger; P J Meier; F J Suchy; M S Anwer
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

6.  Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.

Authors:  Guocai Zhong; Huan Yan; Haimin Wang; Wenhui He; Zhiyi Jing; Yonghe Qi; Liran Fu; Zhenchao Gao; Yi Huang; Guangwei Xu; Xiaofeng Feng; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 7.  The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships.

Authors:  J Geyer; T Wilke; E Petzinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-16       Impact factor: 3.000

Review 8.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Authors:  Aparna Schweitzer; Johannes Horn; Rafael T Mikolajczyk; Gérard Krause; Jördis J Ott
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

9.  Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.

Authors:  V Bruss; J Hagelstein; E Gerhardt; P R Galle
Journal:  Virology       Date:  1996-04-15       Impact factor: 3.616

10.  Effect of S267F variant of NTCP on the patients with chronic hepatitis B.

Authors:  Hye Won Lee; Hye Jung Park; Bora Jin; Mehrangiz Dezhbord; Do Young Kim; Kwang-Hyub Han; Wang-Shick Ryu; Seungtaek Kim; Sang Hoon Ahn
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

View more
  2 in total

Review 1.  Protein-protein interactions of drug uptake transporters that are important for liver and kidney.

Authors:  Yuchen Zhang; Bruno Hagenbuch
Journal:  Biochem Pharmacol       Date:  2019-08-02       Impact factor: 5.858

2.  Moving Fast Toward Hepatitis B Virus Elimination.

Authors:  Leda Bassit; Suzane Kioko Ono; Raymond F Schinazi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.